Economy
Best Hospitals for Thymus Cancer Worldwide
According to the American Association of Oncologists, thymus cancer is rare and accounts for about 0.5% of all tumors. The illness does not show any signs at the initial stage but, at the same time, has a high potential for malignancy. It is characterized by rapid growth and metastasis.
Over the years, we have accumulated statistics on the leading hospitals in Europe and the US for treating thymus cancer. And we can recommend to patients exactly where they will be treated most effectively. So keep reading, and we will share with you the necessary information.
Criteria for selecting the best hospitals for thymus cancer
Not only an error-free diagnosis and the results of further treatment but sometimes life itself depends on the correct choice of the treatment center and attending physician. Therefore, it is necessary to collect all possible information in order not to be disappointed in the chosen hospital in the future:
- Hospitals specialization. It is essential in the treatment of advanced cases of thymus cancer.
- It is necessary to look at clinic articles, scientific developments, and the introduction of various treatment methods for thymus cancer.
- Information about oncologists and thoracic surgeons who work in this hospital.
- It would be good to get acquainted with the reviews of specialists in this field but not working in this clinic.
- It is advisable to choose several hospitals and compare them.
- The second opinion is an opportunity to verify the accuracy of the diagnosis, to hear an alternative point of view of an experienced specialist, or to learn about alternative treatment options.
Finding a hospital with the online service AiroMedical is fast, simple, and effective. It is enough to specify the doctor’s specialty or the disease’s symptoms in the search bar to find the right specialist. Then, in a few seconds, the system will provide you with a relevant list of the hospitals.
Top hospitals for thymus cancer treatment in the United States
University Hospitals Michigan Ann Arbor
Langone Hospital New York
Wisconsin University Hospitals Madison
Benefits of Medical Treatment in the US
Several essential advantages of the list of hospitals in the US:
- Reliable diagnosis, the accuracy of which determines the choice of a treatment plan and the effectiveness of the procedures.
- Hybrid operating rooms, the latest microsurgical and minimally invasive operations equipment.
- World-class thoracic surgeons who are proficient in all modern methods.
Top hospitals for thymus cancer treatment in Europe
University Hospital Frankfurt, Germany
Marien Hospital Marl, Germany
Teknon Medical Centre, Spain
Anadolu Medical Centre, Turkey
Benefits of medical treatment in Europe
European medicine offers the most current opportunities for timely thymus cancer detection and comprehensive diagnosis. Treatment in hospitals in Europe is also:
- World leadership in the number of scientific papers and discoveries in medicine.
- Use of unique developments and author’s methods.
- Careful monitoring of compliance with international standards at all stages of manipulation.
Top hospitals for thymus cancer treatment in Poland
Medicover Hospital Warsaw
European Health Center Otwock
Gamma Knife Exira Center Katowice
Benefits of medical treatment in Poland
Advantages of Polish cancer treatment:
- Fast and accurate examination, low-traumatic technologies.
- Complex treatment, including thymus surgery, chemo, and radiotherapy.
- Remote consultations with doctors after completion of therapy.
Top hospitals for thymus cancer treatment in Italy
University Hospital San Raffaele Milan
European Oncology Institute Milan
Agostino Gemelli University Policlinic Rome
Benefits of medical treatment in Italy
A whole list of hospitals in Italy has such advantages:
- The best doctors with extensive experience treating thymus tumors.
- Diagnostics are carried out on innovative equipment that provides 100% accuracy of results.
- Healthcare costs are more affordable than in America, and the quality is not inferior.
Top hospitals for thymus cancer treatment in Germany
Helios Clinic Berlin-Buch
University Hospital Charite
University Hospital Heidelberg
Benefits of medical treatment in Germany
Several advantages of hospitals in Germany:
- Hybrid operating rooms, robot-assisted surgery.
- Close cooperation of German thoracic surgeons with many narrow specialists.
- Pediatric thoracic surgeons and oncologists are at the disposal of young patients.
Best thymus cancer doctors worldwide
The best doctors in thymus cancer treatment:
Prof. Dr. med. Maximilian Bockhorn
Dr. med. habil. Krzysztof Wrobel
Prof. Dr. Thomas Vogl
Prof. Dr. Hans Hoffmann
Prof. Dr. Helmut Friess
Best treatment solutions for treating thymus cancer
Doctors of the best hospitals in the US and Europe treat thymus cancer using conservative methods and surgically, taking advantage of the latest oncology achievements that allow achieving success in more than 90% of cases. You can read more about each treatment method for thymus cancer on our website.
Here we will mention only a few:
- Da Vinci’s robotic thymectomy. Minimally invasive surgery through four small incisions for the video camera and the robot’s “hands.” The system provides an accurate 3D image of the operating field and the accuracy of movements inaccessible to humans.
- Ablation. A needle-like electrode is inserted into the patient, and an electric current is applied. It leads to a local increase in tissue temperature and the destruction of cancer cells.
- Brachytherapy. It is the irradiation of the tumor with radioactive isotopes from the inside. Unique seeds with an active substance are injected directly into the cancer tissue with the help of endoscopic equipment.
- Targeted therapy. Angiogenesis inhibitors (drugs that prevent the formation of blood vessels) and growth factor inhibitors are most often used.
How to get treatment in the best clinics for thymus cancer
Some diagnoses divide a person’s life into “before” and “after.” You can’t be prepared for them; they sound unfair and scary. Every day in our work, we encounter people tired of endless, fruitless trips to doctors who have almost lost hope of recovery. And how nice it is to see how people’s attitudes to life change after the first positive treatment results.
The AiroMedical project aims to help people who are faced with thymus cancer. On our platform, you will find:
- Consultations of leading oncologists, information about the features of diagnosis and thymus cancer treatment.
- Hospital contacts and appointments for diagnostics and treatment without queues and tedious waiting.
- New therapy methods are used only in a few cancer centers.
Treating thymus cancer with AiroMedical is an opportunity to entrust your health to the best oncologist, constantly improving their professional skills. So leave us a request and get a personalized treatment program.
References
- Semenchuk O. Thymus cancer treatment. AiroMedical. Updated January, 2023. https://airomedical.com/search/thymus-cancer-tymoma
- Kyiashko D. Thymus cancer guide. AiroMedical. Updated March 22, 2023. https://airomedical.com/blogs/disease-guides/thymus-cancer-guide
- Yuan Z., Gao S., Mu J., Xue Q., Mao Y. Long-term outcomes of 307 patients after complete thymoma resection. National library of medicine. Published May 15, 2017. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433013/
By Aduragbemi Omiyale
The deadline for the recapitalisation of the Nigerian pension industry has been extended by six months to June 2027 from December 2026.
This extension was approved by the National Pension Commission (PenCom), the agency, which regulates the sector in the country.
Addressing newsmen on Thursday in Lagos, the Director-General of PenCom, Ms Omolola Oloworaran, explained that the shift in deadline was to give operators more time to boost the capital base, dismissing speculations that the exercise had been suspended.
“The recapitalisation has not been suspended. We have communicated the requirements to the Pension Fund Administrators (PFAs), and we expect every operator to be compliant by June 2027. Anyone who is not compliant by then will lose their licence,” Ms Oloworaran told journalists.
She added that, “From a regulatory standpoint, our major challenge is ensuring compliance. We are working with ICPC, labour and the TUC to ensure employers remit pension contributions for their employees.”
The DG noted that engagements with industry operators indicated broad acceptance of the policy, with many PFAs already taking steps to raise additional capital or explore mergers and acquisitions.
“You may see some mergers and acquisitions in the industry, but what is clear is that the recapitalisation exercise is on track and the industry agrees with us,” she stated.
PenCom wants the PFAs to increase their capital base and has created three categories, with the first consists operators with Assets Under Management of N500 billion and above. They are expected to have a minimum capital of N20 billion and one per cent of AUM above N500 billion.
The second category has PFAs with AUM below N500 billion, which must have at least N20 billion as capital base.
The last segment comprises special-purpose PFAs such as NPF Pensions Limited, whose minimum capital was pegged at N30 billion, and the Nigerian University Pension Management Company Limited, whose minimum capital was fixed at N20 billion.
By Adedapo Adesanya
Three securities weakened the NASD Over-the-Counter (OTC) Securities Exchange by 0.68 per cent on Thursday, December 18.
According to data, Central Securities Clearing System (CSCS) Plc led the losers’ group after it slipped by N2.87 to N36.78 per share from N39.65 per share, Golden Capital Plc depreciated by 77 Kobo to end at N6.98 per unit versus the previous day’s N7.77 per unit, and FrieslandCampina Wamco Nigeria Plc dropped 19 Kobo to sell at N60.00 per share versus Wednesday’s closing price of N60.19 per share.
At the close of business, the market capitalisation lost N16.81 billion to finish at N2.147 billion compared with the preceding session’s N2.164 trillion, and the NASD Unlisted Security Index (NSI) declined by 24.76 points to 3,589.88 points from 3,614.64 points.
Yesterday, the volume of securities bought and sold increased by 49.3 per cent to 30.5 million units from 20.4 million units, the value of securities surged by 211.8 per cent to N225.1 million from N72.2 million, and the number of deals jumped by 33.3 per cent to 28 deals from 21 deals.
Infrastructure Credit Guarantee Company (InfraCredit) Plc remained the most traded stock by value with a year-to-date sale of 5.8 billion units valued at N16.4 billion, followed by Okitipupa Plc with 178.9 million units transacted for N9.5 billion, and MRS Oil Plc with 36.1 million units worth N4.9 billion.
Similarly, InfraCredit Plc ended as the most traded stock by volume on a year-to-date basis with 5.8 billion units traded for N16.4 billion, trailed by Industrial and General Insurance (IGI) Plc with 1.2 billion units sold for N420.7 million, and Impresit Bakolori Plc with 536.9 million units exchanged for N524.9 million.
By Dipo Olowookere
The All-Share Index (ASI) of the Nigerian Exchange (NGX) Limited has again crossed the 150,000-point threshold on Thursday as the demand of for local intensifies.
The market was up by 0.35 per cent during the session, with the NGX index inching higher by 520.23 points to 150,363.05 points from the previous day’s 149,842.82 points and the market capitalisation climbed by N332 billion to N95.857 trillion from N95.525 trillion.
During the session, the consumer goods index grew by 1.23 per cent, the banking counter expanded by 0.56 per cent, and the energy sector appreciated by 0.05 per cent.
However, the insurance industry went down by 0.23 per cent, while the commodity and the industrial goods sectors closed flat.
Nestle Nigeria gained 10.00 per cent to trade at N1,958.00, Guinness Nigeria improved by 9.98 per cent to N289.70, Aluminium Extrusion Industries rose by 9.76 per cent to N11.25, DAAR Communications soared by 9.20 per cent to 95 Kobo, and Mecure Industries surged by 9.13 per cent to N55.00.
On the flip side, Stanbic IBTC lost 9.33 per cent to settle at N95.20, Lasaco Assurance went down by 9.09 per cent to N2.50, Africa Prudential slipped by 8.82 per cent, Austin Laz depreciated by 8.82 per cent to N12.40, and Sterling Holdings crashed by 6.12 per cent to N6.90.
There were 35 price gainers and 26 price losers yesterday, implying a positive market breadth index and bullish investor sentiment.
During the session, a total of 839.8 million equities valued at N32.8 billion exchanged hands in 23,211 deals compared with the 5.9 billion equities worth N216.2 billion traded in 25,205 deals a day earlier, indicating a decline in the trading volume, value, and number of deals by 85.77 per cent, 84.83 per cent, and 7.91 per cent apiece.
The day’s busiest stock was First Holdco with a turnover of 385.6 million units sold for N15.6 billion, FCMB traded 76.0 million units worth N805.3 million, Lasaco Assurance exchanged 43.6 million units valued at N111.8 million, Access Holdings transacted 29.6 million units worth N616.8 million, and Chams sold 24.8 million units valued at N75.4 million.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism9 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking7 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn